Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806182 · ClinicalTrials.gov registry record
Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
A clinical trial of Opsoclonus-myoclonus Syndrome, sponsored by National Pediatric Neuroinflammation Organization.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT00806182 is a study of Opsoclonus-myoclonus Syndrome that has completed, run by National Pediatric Neuroinflammation Organization. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00806182, a study of Opsoclonus-myoclonus Syndrome, has completed, sponsored by National Pediatric Neuroinflammation Organization.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor neuroblastoma.
Conditions Studied
Study Locations (1)
Illinois
- National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-01 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00806182
The ClinicalTrials.gov registry entry for NCT00806182 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Pediatric Neuroinflammation Organization, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opsoclonus-myoclonus Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00806182 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00806182 about?
NCT00806182 is a clinical study titled "Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome". The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor...
What is the current status of trial NCT00806182?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2008-01. Estimated completion is 2016-12.
What conditions does trial NCT00806182 study?
This clinical trial studies the following conditions: Opsoclonus-myoclonus Syndrome.
Who is sponsoring clinical trial NCT00806182?
This trial is sponsored by National Pediatric Neuroinflammation Organization, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00806182 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.